HOMONEREPLACEMENTTHERAPYHRT激素替代疗法HRT
《HOMONEREPLACEMENTTHERAPYHRT激素替代疗法HRT》由会员分享,可在线阅读,更多相关《HOMONEREPLACEMENTTHERAPYHRT激素替代疗法HRT(54页珍藏版)》请在装配图网上搜索。
1、HOMONEREPLACEMEHOMONEREPLACEMENTTHERAPYHRTNTTHERAPYHRT激素激素替代疗法替代疗法HRTHRTWHAT?n nMenopauseisadeviationoftheancientGreekwordsmenos(month)andpauses(ending).n nThemenopauseissometimesknownasthechangeoflifeandismarkedbytheendingofmenstruation.WHAT?n nItbedefinedwithcertaintyaftertwelvemonthsspontaneousam
2、enorrhoea.n nEndofreproductivelife.Age(years)Age(years)Pre-menopausePre-menopausePost-menopausePost-menopauseMENOPAUSEMENOPAUSE1YEAR1YEARPeri-menopause“Climacteric”Peri-menopause“Climacteric”RELATED TERMINOLOGYWHEN?n nMenopausalage:45-55years(mean:50.7years)n nIfthemenopauseoccursinawomanwhoisunder4
3、5yearsofage,itisknownasprematuremenopause.n nLatemenopause:55yearsoldWHEN?n nOtherfactorsthatcanaffecttheageatwhichwomenhavetheirfinalperiodincludeageatmenarche,parity,previousoralcontraceptivehistoryethnicityandfamilyhistory.WHY?RELATIVEACTIVITYOFESTROGENRELATIVEACTIVITYOFESTROGENWHY?n nThemenopaus
4、eistheendofeggproduction(ovulation).Thisoccursasaresultoffallinglevelsofthefemalesexhormoneoestrogen,whichregulatesawomansperiods.WHY?n nThemenopauseresultsfromafallinthelevelofthefemalehormoneoestrogenintheblood.WHY?n nAtahormonallevel-asovarianfollicularactivitybeginstofail,oestrogenandprogesteron
5、elevelsfallandthereducednegativefeedbacktothepituitarycausesariseinluteinisinghormone(LH)andfolliclestimulatinghormone(FSH).HOW?n nOestrogenreductioneventuallyresultsinmenstrualcycledisruptionandothermenopausalsymptoms.HOW?n nOestrogenreductioneventuallyresultsinmenstrualcycledisruptionandothermenop
6、ausalsymptoms.*FSHFSHhighhigh(30170mU/ml)(30170mU/ml)*LH*LHhighhigh(2080mU/ml)(2080mU/ml)*Estradiol*Estradiollowlow(110pmol/L)(110pmol/L)Vasomotor SymptomsVasomotor SymptomsSleep DisordersSleep DisordersMenstrual DisordersMenstrual DisordersMood ChangesMood ChangesVaginal AtrophyVaginal AtrophyDyspa
7、reuniaDyspareuniaSkin AtrophySkin AtrophyOsteoporosisOsteoporosisAtherosclerosisAtherosclerosisCoronary Heart DiseaseCoronary Heart DiseaseCerebrovascular DiseaseCerebrovascular Disease40 yrs40 yrs50 yrs50 yrsMenopauseMenopause60 yrs60 yrsSYMPTOMS!ONSETOFSYMPTOMSINRELATIONTOAGEOFMENOPAUSEONSETOFSYMP
8、TOMSINRELATIONTOAGEOFMENOPAUSESYMPTOMS!n nChangesinyourperiodtimebetweenperiodsorflowChangesinyourperiodtimebetweenperiodsorflowmaybedifferent.maybedifferent.n nHotflashes(“hotflushes”)gettingwarmintheface,Hotflashes(“hotflushes”)gettingwarmintheface,neckandchest.neckandchest.n nNightsweatsandsleepi
9、ngproblemsthatmayleadtoNightsweatsandsleepingproblemsthatmayleadtofeelingtired,stressedortense.feelingtired,stressedortense.n nVaginalchangesthevaginamaybecomedryandVaginalchangesthevaginamaybecomedryandthin,andsexmaybepainful.thin,andsexmaybepainful.n nThinningofyourbones,whichmayleadtolossofThinni
10、ngofyourbones,whichmayleadtolossofheightandbonebreaks(osteoporosis).heightandbonebreaks(osteoporosis).SYMPTOMS!n nItisestimatedthat8outof10womenintheUKexperiencesymptomsleadinguptothemenopause.n nOfthese,45%findtheirsymptomsdifficulttodealwith.SYMPTOMS!n nWithouttreatment,mostmenopausalsymptomsgradu
11、allystopnaturally.Thisusuallyhappenstwotofiveyearsafterthesymptomsstart.n nAlthoughsomewomenexperiencesymptomsformanymoreyears.SYMPTOMS!SYMPTOMS!NORMALTRABECULARBONENORMALTRABECULARBONEOSTEROPEROTICBONEOSTEROPEROTICBONETREATMENTn nOnly1in10womenseekmedicaladvicewhentheygothroughthemenopauseandmanydo
12、notneedanytreatment.n nIfmenopausalsymptomsaresevereenoughtointerferewithdailylife,therearetreatmentsthatcanhelp.TREATMENTn nThekindoftreatmentyoucantakedependsontheseverityofthesymptoms,medicalhistoryandpatientsownpreferences.TREATMENTn nHRTn nNON-HRTHOMONE REPLACEMENT THERAPY(HRT)n nAsthenamesugge
13、sts,HRTworksbyreplacingoestrogen.n nHormonereplacementtherapy(HRT)canbeaneffectivetreatmentforthetypicalmenopause-relatedsymptoms.HOMONE REPLACEMENT THERAPY(HRT)n nHRTmayalsohaveaninfluenceonthelongtermhealthproblems(osteoporosis,cardiovascular diseaseandstroke),thoughitshouldbenotedthatitdoesnotnec
14、essarilyreducetheirriskforallwomen.HOMONE REPLACEMENT THERAPY(HRT)BENEFITSBENEFITSRISKSRISKSHOMONE REPLACEMENT THERAPY(HRT)n nForthetreatmentofmenopausalsymptomswheretherisk-benefitratio*isfavorable,infullyinformedwomen,inthelowestpossibledosetocontrolsymptomsandfortheshortestdurationpossible.HOMONE
15、 REPLACEMENT THERAPY(HRT)n nBENEFITSRelievemenopausalsymptomsMaintenanceofqualityoflifePreventionofosteoporosisNote:HRTshouldnotbeusedasafirst-linetreatmentinosteoparosisNote:HRTshouldnotbeusedasafirst-linetreatmentinosteoparosisexceptinwomenwhohaveexceptinwomenwhohavepremature menopausepremature me
16、nopause HOMONE REPLACEMENT THERAPY(HRT)n nRISKS OF VTEHRT(combinedoroestrogen-alone)increasestheriskofHRT(combinedoroestrogen-alone)increasestheriskofadeepveinthrombosisorpulmonaryembolism,adeepveinthrombosisorpulmonaryembolism,especiallyinthefirstyearoftreatment.Theriskismoreespeciallyinthefirstyea
17、roftreatment.Theriskismorepronouncedinwomenwithpre-existingriskfactors.pronouncedinwomenwithpre-existingriskfactors.Arecentmeta-analysissuggeststhattransdermalArecentmeta-analysissuggeststhattransdermaloestrogensmaybeasaferoptionthanoraloestrogensforoestrogensmaybeasaferoptionthanoraloestrogensforHR
18、THRT.HOMONE REPLACEMENT THERAPY(HRT)n nRISKS OF BREAST CANCERn nTheThe increasedincreased breastbreast cancercancer riskrisk isis proportionalproportional toto thethedurationdurationofofHRT.HRT.HRTHRTincreasesincreasesthisthisriskriskbybyaboutabout1.6times1.6timesafterafter55yearsyears ofofuseuseand
19、and2.3times2.3timesafterafter10years10years ofofuse.use.RiskdecreaseswithinafewyearsofstoppingHRT.RiskdecreaseswithinafewyearsofstoppingHRT.n nWomenWomen consideringconsidering HRTHRT shouldshould bebe counselledcounselled thatthat thetheabsoluteabsoluteriskriskforforbreastbreastcancercancerforforan
20、yanyindividualindividualremains remains relatively low*relatively low*HeractualriskincreasesHeractualriskincreases0.08%0.08%(ACOG)(ACOG)HOMONE REPLACEMENT THERAPY(HRT)n nRISKS OF ENDOMETRIAL CANCEREndometrialcancer:increasedriskonlywithunopposedEndometrialcancer:increasedriskonlywithunopposedoestrog
21、en.Thereisnoincreasedriskwithcombinedoestrogen.Thereisnoincreasedriskwithcombined(oestrogenandprogestogen)HRT.(oestrogenandprogestogen)HRT.RISKS OF OVARIAN CANCERlong-termuseofoestrogen-onlyHRTandcombinedHRTlong-termuseofoestrogen-onlyHRTandcombinedHRTmayslightlyincreasetherisk.Riskdecreasesaftermay
22、slightlyincreasetherisk.RiskdecreasesafterstoppingHRT.stoppingHRT.HOMONE REPLACEMENT THERAPY(HRT)n nRISKS OF CARDIOVASCULAR DISEASEThereisnotthesameevidenceofThereisnotthesameevidenceofcardioprotectionfromHRTaswasoriginallycardioprotectionfromHRTaswasoriginallythought.thought.AssessallwomensriskofCH
23、DpriortostartingAssessallwomensriskofCHDpriortostartingHRT.HRT.HOMONE REPLACEMENT THERAPY(HRT)HOMONE REPLACEMENT THERAPY(HRT)s sSequentially Sequentially combined HRTcombined HRT E(continuouslyE(continuouslyD1-D21)D1-D21)P(sequentiallyP(sequentiallyD11-D21)D11-D21)Continuous Continuous combined HRTc
24、ombined HRT E&PE&P(continuous:D1-(continuous:D1-D28)D28)HOMONE REPLACEMENT THERAPY(HRT)n nWomen with an intact uterusWomen with an intact uterusVasomotorsymptomsVasomotorsymptomsn nPerimenopausal:systemiccyclicalcombinedHRT.Perimenopausal:systemiccyclicalcombinedHRT.n nPostmenopausal:systemiccontinu
25、ouscombinedPostmenopausal:systemiccontinuouscombinedHRTortibolone.HRTortibolone.UrogenitalsymptomsUrogenitalsymptomsn nPerimenopausal:low-dosevaginaloestrogenorPerimenopausal:low-dosevaginaloestrogenorsystemiccyclicalcombinedHRT.systemiccyclicalcombinedHRT.n nPostmenopausal:low-dosevaginaloestrogeno
26、rPostmenopausal:low-dosevaginaloestrogenorsystemiccontinuouscombinedHRT.systemiccontinuouscombinedHRT.HOMONE REPLACEMENT THERAPY(HRT)n nWomen who have had a hysterectomyWomen who have had a hysterectomyVasomotorsymptoms:systemicoestrogen-onlyHRT.Vasomotorsymptoms:systemicoestrogen-onlyHRT.Urogenital
27、symptoms:low-dosevaginaloestrogenorUrogenitalsymptoms:low-dosevaginaloestrogenorsystemicoestrogen-onlyHRT.systemicoestrogen-onlyHRT.HOMONE REPLACEMENT THERAPY(HRT)HOMONE REPLACEMENT THERAPY(HRT)CONTRAINDICATIONS OF HRT!n nPregnancy and breast-feedingPregnancy and breast-feedingn nUndiagnosed abnorma
28、l vaginal bleedingUndiagnosed abnormal vaginal bleedingn nVenous thromboembolic diseaseVenous thromboembolic diseasen nActive or recent Active or recent anginaangina or or myocardial infarctionmyocardial infarctionn nSuspected,current or past breast cancerSuspected,current or past breast cancern nEn
29、dometrial cancer or other oestrogen-dependent cancerEndometrial cancer or other oestrogen-dependent cancern nActive liver disease with abnormal Active liver disease with abnormal liver function testsliver function testsSTART-UP SYMPTOMS OF HRT!n nBreast tendernessBreast tendernessn nNipple sensitivi
30、tyNipple sensitivityn nBloatingBloatingn nNausea,headachesNausea,headachesn nAppetite Appetite n nWeight gainWeight gainn nLeg crampsLeg crampsINVESTIGATIONS BEFORE HRT!Investigations are not usually necessary before Investigations are not usually necessary before starting HRT unless there is:starti
31、ng HRT unless there is:n nsudden change in menstrual pattern(IMB/PCB)sudden change in menstrual pattern(IMB/PCB)n nHigh risk of breast cancerHigh risk of breast cancern nPersonal/family history of VTEPersonal/family history of VTEn nWoman has arterial risk factorsWoman has arterial risk factorsALTER
32、NATIVE TO HRT!“Tibolone”is a synthetic hormone that acts in the “Tibolone”is a synthetic hormone that acts in the same way as HRT same way as HRT(SERM)(SERM)n nUsefulforpost-menopausalwomenwhowanttoendUsefulforpost-menopausalwomenwhowanttoendtheirperiods.theirperiods.n nWhichhasoestrogenic,progestog
33、enicandandrogenicWhichhasoestrogenic,progestogenicandandrogenicpropertiesproperties.(.(estrogenicactivityinestrogenicactivityinbonebone,CNSvasomotor,CNSvasomotorsuppressionofsuppressionofhotflusheshotflushesandandhelpfulinimprovingsexualfunction.helpfulinimprovingsexualfunction.STARTING HRT!“A full
34、physical examination is mandatory”A full physical examination is mandatory”n nFull blood countFull blood countn nRenal ProfileRenal Profile-Baseline-Baselinen nLiver Function TestLiver Function Testn nLipid profileLipid profileFOLLOW UP OF TAKING HRT!n nReviewthewoman3monthsafterstartingHRTReviewthe
35、woman3monthsafterstartingHRTandonceeachyearthereafter.andonceeachyearthereafter.n nAt3-months:At3-months:Enquireaboutbleedingpatterns,checkbloodEnquireaboutbleedingpatterns,checkbloodpressure,andbodyweight.pressure,andbodyweight.AssesstheeffectivenessoftreatmentandAssesstheeffectivenessoftreatmentan
36、dadjusttoachievesymptomcontrol.adjusttoachievesymptomcontrol.EnquireaboutadverseeffectsandmanageEnquireaboutadverseeffectsandmanageappropriately.appropriately.FOLLOW UP OF TAKING HRT!n nOnceeachyear:Onceeachyear:Checkbloodpressure,effectivenessoftreatmentandCheckbloodpressure,effectivenessoftreatmen
37、tandadjusttoachievesymptomcontrol.adjusttoachievesymptomcontrol.EnquireaboutadverseeffectsandmanageEnquireaboutadverseeffectsandmanageappropriately.appropriately.ConsiderswitchingfromcyclicalHRTtoConsiderswitchingfromcyclicalHRTtocontinuouscombinedHRT,ifappropriate.continuouscombinedHRT,ifappropriat
38、e.FOLLOW UP OF TAKING HRT!DiscusstherisksandbenefitsofHRT.DiscusstherisksandbenefitsofHRT.PerformabreastexaminationifindicatedbypersonalPerformabreastexaminationifindicatedbypersonalorfamilyhistory.orfamilyhistory.EncouragebreastawarenessandparticipationintheEncouragebreastawarenessandparticipationi
39、nthenationalbreastscreeningprogrammeasappropriatenationalbreastscreeningprogrammeasappropriatefortheirage.fortheirage.PelvicexaminationisrequiredonlyifclinicallyPelvicexaminationisrequiredonlyifclinicallyindicatedindicatedNON-HRTLifestyle modificationLifestyle modificationStop smokingStop smokingHea
40、lthy dietHealthy dietWeight controlWeight controlRegular moderate-intensity exerciseRegular moderate-intensity exerciseControl blood pressure and cholesterolControl blood pressure and cholesterolNON-HRTn nFor vasomotor symptoms For vasomotor symptoms Atrial(2weeks)ofparoxetine,fluoxetineAtrial(2week
41、s)ofparoxetine,fluoxetinecitalopramorvenlafaxine(SSRI)citalopramorvenlafaxine(SSRI)Atrial(24weeks)ofclonidineAtrial(24weeks)ofclonidineAprogestogensuchasnorethisteroneorAprogestogensuchasnorethisteroneormegestrolmegestrolNON-HRTn nFor vaginal drynessFor vaginal drynessVaginallubricantormoisturizer,s
42、uchasReplensVaginallubricantormoisturizer,suchasReplens.NON-HRTn nFor osteoporosisAlendronate(Alendronate(FosamaxFosamax)RocaltriolRocaltriolAlpha-calcidolAlpha-calcidolRaloxifene(Raloxifene(EvistaEvista)NON-HRTn nFor psychological symptoms-Self-helpgroupsSelf-helpgroups-Psychotherapy-Psychotherapy-
43、Otherformsofcounselling-Otherformsofcounselling-Antidepressants.-Antidepressants.NON-HRTComplementary therapiesn nRemifemin(Cimicifugarhizomeextract)Remifemin(Cimicifugarhizomeextract)n nRedcloverplantRedcloverplant n nSoyproductsSoyproductsn nEveningprimroseEveningprimrosen nBlackcohoshBlackcohoshn
44、 nPhytoestrogensPhytoestrogensn nGinsengGinsengNON-HRTComplementary interventionsComplementary interventionsn nAcupunctureAcupuncturen nReflexologyReflexologyDiet and supplementsDiet and supplementsn nVitamins and mineralsVitamins and mineralsn nVitamin EVitamin EHomeopathyHomeopathyPremature menopa
45、use?n nMenopausalsymptomsinwomenwhoareyoungerthanMenopausalsymptomsinwomenwhoareyoungerthan40years(1%)40years(1%)n nOfferlifestyleadvice.Offerlifestyleadvice.n nOffersystemichormonereplacementtherapy(HRT)orOffersystemichormonereplacementtherapy(HRT)orthecombinedoralcontraceptivepill(COC)thecombinedoralcontraceptivepill(COC)n nDecreasedlibido:testosteroneimplantsandpatchesDecreasedlibido:testosteroneimplantsandpatchesmaybeconsideredmaybeconsideredTHANK YOU结束结束
- 温馨提示:
1: 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
2: 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
3.本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
5. 装配图网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。